Fig. 1 · Structure

Documents & Downloads

Milvexian TFA

Factor Xia Antagonist

Milvexian TFA is a selective factor XIa inhibitor that effectively prevents venous thromboembolism. This compound has demonstrated efficacy in reducing venous thromboembolism rates in patients undergoing knee replacement surgery. Additionally, Milvexian TFA exhibits significant inhibitory activity against plasma kallikrein and trypsin, with a favorable bioavailability of 32%. Clinical trials indicate that Milvexian TFA presents a relatively low risk of bleeding, making it a promising candidate for further research in thrombotic disorders.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1802426-00-1
Applications

Factor Xia Antagonist

Formula C30H24Cl2F5N9O4
Molecular Weight 740.47
Synonyms BMS-986177 TFA; JNJ-70033093 TFA
SMILES
O=C(NC1=C2N(C(F)F)N=C1)[C@H](C)CCC[C@H](N(C=NC(C3=CC(Cl)=CC=C3N4N=NC(Cl)=C4)=C5)C5=O)C6=CC2=CC=N6.OC(C(F)(F)F)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...